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Abstract
By adapting to the actual patient anatomy during treatment, tracked multi-
leaf collimator (MLC) treatment deliveries offer an opportunity for margin 
reduction and healthy tissue sparing. This is assumed to be especially relevant 
for hypofractionated protocols in which intrafractional motion does not easily 
average out. In order to confidently deliver tracked treatments with potentially 
reduced margins, it is necessary to monitor not only the patient anatomy but 
also the actually delivered dose during irradiation. In this study, we present 
a novel real-time online dose reconstruction tool which calculates actually 
delivered dose based on pre-calculated dose influence data in less than 10 ms 
at a rate of 25 Hz. Using this tool we investigate the impact of clinical target 
volume (CTV) to planning target volume (PTV) margins on CTV coverage 
and organ-at-risk dose. On our research linear accelerator, a set of four 
different CTV-to-PTV margins were tested for three patient cases subject 
to four different motion conditions. Based on this data, we can conclude 
that tracking eliminates dose cold spots which can occur in the CTV during 
conventional deliveries even for the smallest CTV-to-PTV margin of 1 mm. 
Changes of organ-at-risk dose do occur frequently during MLC tracking 
and are not negligible in some cases. Intrafractional dose reconstruction is 
expected to become an important element in any attempt of re-planning the 
treatment plan during the delivery based on the observed anatomy of the day.
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1. Introduction
Dynamic multi-leaf collimator (MLC) tracking is an emerging form of adaptive radiotherapy 
suitable for tumours which are affected by intrafractional motion. On conventional C-arm lin-
acs, the use of MLC tracking has been reported for a small number of prostate patients (Keall 
et al 2014, Colvill et al 2015) giving some early indications about clinical usefulness. The ben-
efit of applying MLC tracking to more mobile tumour sites such as lung is hypothesised, but 
as of today not demonstrated in clinical studies. Additionally, a much larger body of literature 
ranging back almost 15 years is available (Keall et al 2001, Tacke et al 2010, Fast et al 2014), 
mostly dealing with the technicalities of how to implement MLC tracking for the different linac 
vendors. MLC tracking, in its currently prevalent form, is focussed on dynamically reshaping 
the treatment field in the beam’s-eye-view according to the actual recorded target motion. This 
is sometimes referred to as translational or centroid tracking. Popular target detection devices 
are linac-mounted x-ray imagers (Poulsen et al 2010, Fast et al 2012) and the electromagnetic 
transponder-based localisation system (Keall et al 2011, Krauss et al 2011), both relying on 
implanted markers. Newly emerging, non-invasive and yet largely untested (in the context of 
radiotherapy) target detection techniques are ultrasound imaging (Schlosser et al 2010) and 
magnetic resonance (MR) imaging (Crijns et al 2012, Yun et al 2013). Especially the latter 
technique holds a lot of promise when available on a MR-guided delivery machine. Due to their 
superior soft-tissue contrast, MR images are expected to visualise not only target translations, 
but also target rotations and deformations as well as organ-at-risk (OAR) motion.
In this study, the focus will be on the dosimetric implications of dynamic MLC tracking 
during hypofractionated prostate irradiation. Currently, the calculation of actually delivered 
dose can only be conducted after the treatment fraction due to its computational cost, missing 
real-time data interfaces and compatibility issues with commercial treatment planning systems 
(TPS). Typical and well-publicised offline reconstruction techniques use a probability density 
function of the target position to either convolve the 3D dose or the 2D fluence (Lujan et al 
1999, Waghorn et al 2010). As discussed by Poulsen et al (2012), these methods fail to cor-
rectly capture the machine/target motion interplay caused by adding dynamic MLC tracking. 
Alternatively, Poulsen et al (2012) propose the now frequently used rigid shift method: intra-
fractional target positions are grouped into discrete motion intervals, sub-beams are defined as 
part of the treatment corresponding to each motion interval, the target shift is modelled by rig-
idly shifting the sub-beam isocenter, and finally dose is calculated in a commercial TPS using 
a motion-encoded treatment plan. While this method correctly accounts for the machine/target 
motion interplay, the assumption that the anatomy surrounding the target is rigidly shifting in 
parallel with the target (thus invalidating the derived dose values for adjacent tissue that does 
not meet this condition) and the discretisation of motion could be seen as drawbacks. More 
recently, Ravkilde et al (2014) have presented an offline dose reconstruction algorithm spe-
cifically geared towards MLC tracking using a simplified pencil beam convolution algorithm.
To overcome the limitations of offline dose reconstruction, we are presenting a software 
solution which allows for real-time online dose reconstruction of dynamic radiotherapy deliv-
eries. Online dose reconstruction is an essential link in the chain of online adaptive radiother-
apy and the methodology developed for this study is expected to inform re-planning decisions 
impacting on the dose delivery at the time of treatment. In future, this might enable automated 
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interventions with the possibility of updating treatment prescriptions before each beam in 
the case of step-and-shoot deliveries or even before each segment. Additionally, online dose 
reconstruction could potentially expedite the clinical adoption of MLC tracking by increas-
ing confidence in the actually delivered dose. One of the main perceived advantages of MLC 
tracking is the ability to spare healthy tissue not only by continuously realigning the beam 
with the target, but also by shrinking the proportion of the treatment field margin directly 
related to interfractional and intrafractional motion. Using our new software, we investigated 
the impact of reduced margins on target coverage and OAR sparing.
2. Materials and methods
Dynamic MLC tracking was previously demonstrated at our institution for the Elekta Agility 
MLC (Stockholm, Sweden) hosted on a Synergy research linac (Fast et al 2014). While the 
previous study focussed on the technical aspects of realising MLC tracking such as system 
latencies and residual geometric errors, this study has seen our in-house developed control 
software for delivery and tracking, DynaTrack, expanded for full step-and-shoot IMRT deliv-
eries. For the purpose of this study, a total of three delivery modes were implemented on our 
research linac.
 • Static—no anatomical motion and no MLC tracking. The reconstructed dose is expected 
to be identical to the planned dose.
 • Conventional—intrafractional anatomical motion, but no MLC tracking. This corresponds 
to the current standard of care. The reconstructed dose is expected to reveal changes in 
the target dose when compared to the static delivery. The effects of interfractional motion 
were also investigated for a small number of sample cases.
 • Tracked—intrafractional target motion is compensated by MLC tracking. The recon-
structed dose is expected to reveal that target dose is comparable and that OAR dose 
changes when comparing to the static delivery.
2.1. Online dose reconstruction software
Our dose reconstruction software is schematically shown in figure 1. DynaTrack is interfaced 
to our research linac and controls treatment delivery and MLC tracking via a proprietary 
real-time tracking interface provided by Elekta. Actual MLC apertures and machine states are 
reported to DynaTrack every 40 ms and 20 ms respectively. Each MLC aperture is associated 
with the corresponding machine state (i.e. monitor units, dose rate, gantry angle and beam-on 
state) before being processed. Simulated 3D target positions based on measured prostate tra-
jectories (see section 2.3) are updated at 25 Hz. An additional artificial latency of 100 15±  ms 
is applied to the target positions to emulate the localisation latency of the Calypso system 
(Krauss et al 2011).
While DynaTrack is solely responsible for acquiring the target motion and controlling the 
treatment delivery, it is also connected to our in-house developed TPS, DynaPlan, via the 
TCP/IP networking protocol to facilitate dose reconstruction. For this study, DynaPlan was 
installed on a Windows 7 workstation computer equipped with two Intel Xeon E5-2697 v3 
2.6 GHz CPUs in dual configuration. TCP/IP was chosen to allow DynaTrack and DynaPlan 
to run on different computers, and to ensure that each status package is actually sent and 
received. DynaTrack sends MLC apertures and target position updates to DynaPlan as soon as 
they become available using two independent TCP/IP connections. Separate connections were 
required as the data stem from two independent devices (linac and motion simulator) and are 
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thus asynchronous by nature. To avoid a bunching of data, the TCP/IP receiver is organised 
in a separate thread independent of the computing-heavy dose reconstruction calculations. 
A third TCP/IP connection is used to send the content of the RT structure file to DynaTrack 
which is important for setting up the delivery correctly.
To facilitate dose accumulation, DynaPlan relies on the ultrafast μKonRad dose calcul-
ation engine (Ziegenhein et al 2008, 2013). μKonRad uses a set of pre-calculated dose influ-
ence matrices (Dij) generated in RayStation 4.6 (research version, RaySearch Laboratories, 
Stockholm, Sweden) using its singular value decomposed pencil beam algorithm to calculate 
the actually delivered dose. Beamlets were calculated independently for each beam for the 
CTV plus a 2.5 cm isotropic expansion to cover the range of anticipated target motion.
The main dose reconstruction thread continuously queries the receiver thread for new 
and unprocessed MLC apertures and performs the following tasks as soon as a new aperture 
becomes available:
 (i) find the target position closest in time based on the data time stamps,
 (ii) identify the corresponding set of beamlets based on the gantry angle,
 (iii) assign weights to each beamlet according to its geometric overlap with the MLC,
 (iv) start off a dose calculation for each beamlet,
 (v) multiply each dose with the incremental MUs since the last reported aperture,
 (vi) map the accumulated dose onto the planning CT (see section 2.3).
During step (vi), special consideration was given to the target volume-of-interest, which 
was mapped according to the target position associated with each aperture. In step (iii), special 
consideration was given to beamlets partially covered by the Y collimators and/or the leaves. 
For these beamlets, the weighting factor was linearly interpolated between the two states 
of closed (zero) and open (one). To avoid issues arising from the scheduler of the operating 
system and to balance the CPU load, steps (i) to (v) were also performed for apertures with 
incremental MU equal to zero i.e. beam-off. Although most measurements were performed 
as online dose reconstruction, it is important to note that certain additional batch calculations 
(i.e. rotations and interfractional motion, see section 2.3) were performed offline based on 
previously acquired online data. In these cases the large parameter space made online meas-
urements impractical. For the offline mode, the dose reconstruction works in a similar way to 
the online mode outlined above by looping over the list of previously stored MLC apertures 
and target positions instead of requiring an active connection with DynaTrack.
Figure 1. Schematic view of the online dose reconstruction platform. Connections for 
online use are shown as solid lines, offline connections are dashed. Interfaces explicitly 
implemented for this study are shown in red.
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A 5 5×  mm2 beamlet resolution was chosen for most measurements. The dose was accu-
mulated onto a voxel grid derived from the planning CT by binning voxels by a factor of two 
in both transversal directions. The computed dose grid resolution was 2.3 2.3 1.5× ×  mm3 
(patient 1), 2.1 2.1 1.5× ×  mm3 (patient 2) and 1.9 1.9 1.3× ×  mm3 (patient 3). The dose 
reconstruction was limited to slices 29–121 to reduce computation times. We have also tested 
a finer sampling (2.5 mm and 1.25 mm) in the direction parallel to the MLC leaves in offline 
reconstruction mode for a small subset of cases.
2.2. Patient cohort and planning rationale
To facilitate this investigation, we selected three typical prostate patients. The relevant patient 
characteristics are summarised in table 1. Note our use of V95% (total volume receiving 95% 
of the prescribed dose) overlap with the OAR as a proxy for the target-to-OAR distance. While 
data for patient 1 was used in a previous trial in Sydney (Ng et al 2012), data for patients 
2 and 3 were newly acquired at our institute. All plans were specifically generated for this 
study according to the clinical dose constraints and fractionation scheme (5 Fx) outlined in 
the RTOG 0938 guidelines. The number of beams was 7 (patient 1 and 3) and 9 (patient 2). 
The standard 6 MV flattened beam was used for all deliveries. A total of four step-and-shoot 
IMRT plans were generated for each patient using (i) a RTOG-compliant CTV-to-PTV margin 
of 5 mm reduced to 3 mm posteriorly or (ii–iv) isotropic margins of 1 mm, 3 mm and 5 mm 
respectively. Plans were generated in Pinnacle (patient 1 and 3) and RayStation (patient 2).
2.3. Motion conditions
To simulate intrafractional motion, we have identified four previously recorded prostate tra-
jectories which represent a range of possible motion conditions including a baseline drift 
Table 1. Patient cohort used in this study.
CTV PTV
Rectum 
V95%
Bladder 
V95%
 
NTID
(litre  ×  Gy)
(cm3)
Patient #1 55.4
CTV+1 mm 70.4 0.5 12.7 37
CTV+3 mm 89.6 1.7 19.6 41.5
CTV+5 mm 111.5 2 25.1 46.5
CTV+5/3 mm 104.3 1.5 25.2 46
Patient #2 41.5
CTV+1 mm 50.2 2.9 7.9 42
CTV+3 mm 69.1 3.1 12 47
CTV+5 mm 89.2 3.9 17.7 51
CTV+5/3 mm 84.5 2.9 16.9 50.5
Patient #3 51.6
CTV+1 mm 66 1.8 7.6 38
CTV+3 mm 84.4 4 13.9 45
CTV+5 mm 110.4 6.1 17.6 50
CTV+5/3 mm 106.2 4.3 16.6 47
Note. Non-tumour integral dose (NTID) is introduced in section 2.4.
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posteriorly and inferiorly (continuous drift), a baseline drift posteriorly and inferiorly with 
sudden transient motion mostly anteriorly (erratic), a slow baseline drift anteriorly and superi-
orly with sudden transient motion anteriorly and superiorly (high frequency), and a trajectory 
with little motion (stable). All of the trajectories were recorded for a previous study using the 
Calypso electromagnetic localisation system (Langen et al 2008). For a pictorial representa-
tion of the trajectories, see figures 1(a)–(c) (continuous drift, high frequency and erratic) and 
figure 3 (stable) in Langen et al (2008).
The motion trajectories were then used during the conventional and tracked deliveries to 
inform a simple motion model. The motion model assumes that the entire PTV is translated 
according to the trajectory, while the surrounding OARs remain static for want of a better 
OAR motion description. During dose accumulation, target dose was thus effectively mapped 
back into the target structure as defined on the planning CT. From a dose calculation point 
of view, the prostate motion model is justified based on the fact that the tissue surrounding 
the prostate is very homogenous and mostly of water-equivalent electron density, with the 
exception of pelvic bone which is sometimes quite near. To further underline the validity of 
our motion model, we have also implemented a second method similar to the rigid shift model 
introduced by Poulsen et al (2012). Here, instead of moving the target volume-of-interest 
(VOI) within the planning CT and the MLC aperture at the same time (‘MLC+VOI’), we 
keep the planning CT static and apply the residual shift of MLC motion minus target motion 
in beam’s-eye-view to the MLC (‘MLC-only’). The two methods were then compared for a 
small number of tracked deliveries.
Interfractional motion was only considered for a subset of the conventional deliveries by 
applying a constant offset vector to the intrafractional motion. This was done to estimate the 
impact of residual beam-to-target misalignment even after performing online image guid-
ance (McNair et al 2008). Offset vectors from  −3 mm to  +3 mm in 1 mm steps in all three 
directions (and all combinations thereof resulting in 343 different dose reconstructions) were 
considered. For the tracked deliveries, the interfractional offset is implicitly corrected for and 
was thus not considered in this study.
Finally, prostate rotations were also applied on top of the translations during the recon-
struction to investigate the potential impact on target coverage in tracked deliveries. Wu et al 
(2012) demonstrated how MLC tracking can accurately account for rotated targets but this 
was beyond the scope of this study. Instead, MLC tracking followed the translational motion 
of the target only. For all patients, pitch rotations about the left-right (LR) axis of the centre of 
volume, ranging from 20− ° to 20+ ° in 1° steps, were investigated, since this type of rotation 
was found to be predominant in previous studies (Hoogeman et al 2005, Deutschmann et al 
2012, Zhu et al 2013). Different combinations of pitch rotations with roll rotations about the 
superior-inferior (SI) axis, sampling the same angular range in 4° steps (121 different dose 
reconstructions), were additionally calculated, following the Euler convention of first pitch, 
then roll. Yaw rotations about the anterior-posterior (AP) axis were not investigated in this 
study. To exclude any interplay effects, the rotation was applied to the entire treatment frac-
tion. Note that we also allowed for negative rotations in our study, as the planning CT might 
be a snapshot depicting a forward-rotated prostate.
2.4. Delivery analysis
The different delivery techniques, patient, plan and motion scenarios were compared by cal-
culating dose volume histograms (DVH) for each VOI from the original treatment plans after 
completing the dose reconstruction. For these DVH calculations, all VOIs were treated as 
non-exclusive volumes meaning that some voxels were shared between volumes in the case 
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of overlapping structures. From the DVHs, special points of interest such as CTV D98, PTV 
D95, rectum D2 and bladder D2 were then extracted. To compare the static treatment plans, 
the V95% for OARs and the non-tumour integral dose were computed. Following the defini-
tion by D’Souza and Rosen (2003) and assuming constant mass density jρ  across an organ j, 
the integral dose Ij to that organ is given by:
I
V
N
D ,j j
j
j i
N
i
j
∑ρ= (1)
where Vj is the volume and Nj is the number of voxels i with dose Di. The non-tumour ‘organ’ 
was derived by subtracting the CTV from the body VOI.
3. Results
Some of the dose characteristics of the different treatment plans are characterised in table 1. 
As expected, the overlap of V95% and OARs increases with margin. Although the overlap is 
also influenced by the conformity of the plan and generally by the clinical constraints on the 
optimiser, it indicates that the rectum-to-target distance is shortest for patient 1 and that the 
bladder-to-target distance is shortest (jointly) for patients 2 and 3. The non-tumour integral 
dose (1) is almost identical for patients 1 and 3 and slightly increased for patient 2, for which 
9 beams were used instead of 7. Again as expected, an increase of non-tumour integral dose 
with margin is observed.
3.1. Dosimetric impact of intrafractional motion
Figures 2–4 summarise the findings for all patients and all combinations of plan and motion 
parameters. Importantly, all dosimetric results Dx are shown relative to their respective static 
case, which was considered the RTOG-compliant gold standard delivery. Results are always 
shown for a single fraction only, as intrafractional motion can vary strongly between fractions. 
The D95 prescription level (725 cGy for a single fraction) is indicated for the PTV.
For patient 1 (figure 2), the high frequency trajectory has a major impact on the target 
coverage for the conventional delivery. Substantial cold spots appear in the CTV and the PTV. 
The latter structure violates its RTOG prescription threshold for all margins. Tracking is able 
to recover the target dose in all these cases. In terms of the OAR D2 doses, tracking intro-
duces a tradeoff between the rectum and the bladder. Predominant motion towards the rectum 
(continuous drift) increases rectum dose and decreases bladder dose. For the high frequency 
trajectory, which moves predominantly towards the bladder, the trend is reversed. It it instruc-
tive to note that for the CTV+1 mm tracked deliveries, rectum and bladder dose increases lead 
to absolute dose values on par or below the respective values from the CTV+5/3 mm static 
delivery.
For patient 2 (figure 3), cold spots appear in the target in the conventional delivery for the 
continuous drift, the erratic and the high frequency trajectories. Interestingly, there is no clear 
trend for a reduction in CTV cold spots with margin. Again, tracking successfully removes 
these cold spots for all cases. For the OAR D2 in tracked deliveries, the tradeoff between 
rectum and bladder depending on the motion trajectory, as previously seen in patient 1, is 
repeated. When the CTV+1 mm tracked deliveries are compared to the CTV+5/3 mm static 
delivery, rectum D2 sometimes exceeds the static delivery whereas bladder D2 is lower in all 
cases.
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Lastly, for patient 3 (figure 4), it is again the high frequency trajectory that results in large 
target cold spots for the conventional delivery. It is noticeable that the CTV cold spots reduce 
with margin increase, whereas the PTV cold spots do not. For the CTV+5 mm plan, the PTV 
D95 falls short of the RTOG prescription by 31 cGy. As seen for some plans of patient 2, the 
high frequency trajectory leads to a substantial reduction in bladder D2 for the conventional 
delivery. This is due to the fact that patient 3 (just like patient 2) has a relatively short target-to-
bladder distance and that the high frequency trajectory is moving predominantly towards the 
bladder. Dose which is usually deposited into the bladder is thus received by the target instead. 
Similar to patient 1, rectum and bladder dose increases for the CTV+1 mm tracked deliver-
ies lead to absolute dose values on par or below the respective values from the CTV+5/3 mm 
static delivery.
3.2. Computing performance
The online dose reconstruction was updated for each MLC aperture reported by the linac 
(25 Hz) and took 8.8 1.0±  ms (min: 7.5 ms, max: 12.9 ms) per aperture at the 5 5×  mm2 beam-
let resolution. Beamlet data of up to 1 GB per segment was handled at a memory throughput of 
75.6 8.5±  GB sec−1 (min: 51.2 GB sec−1, max: 87.6 GB sec−1) on a single workstation comp-
uter. Memory throughput was observed to be roughly constant for finer beamlet resolutions, 
resulting in dose reconstruction times increasing linearly with total beamlet data. The typical 
total number of dose calculations was of the order of 8000 for a 5.3 min delivery.
Figure 2. Patient 1: all results are relative to the respective Dx from the static deliveries. 
Results for each trajectory always come in pairs of conventional/tracked. Note that some 
dose differences are very small and thus not visible and that some bars are cropped.
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Figure 3. Patient 2: all results are relative to the respective Dx from the static deliveries 
(see legend and caption of figure 2).
Figure 4. Patient 3: all results are relative to the respective Dx from the static deliveries 
(see legend and caption of figure 2).
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3.3. Impact of beamlet resolution
The effect of the different beamlet resolutions is shown in figure 5. All dose differences were 
calculated relative to the 5 1.25×  mm2 beamlet resolution which was assumed to be the gold 
standard. The dose difference is most pronounced at the edge of the segments and therefore 
also in an annulus around the PTV. It is noteworthy that for the 5 1.25×  mm2 beamlet resolu-
tion, the dose distribution is ‘tighter’, meaning that dose is shifted from just outside of the 
segment (in beam’s-eye-view) to just inside the segment. This is due to the fact that in the 
case of a partial overlap of the MLC leaf with a beamlet, dose is distributed equally across this 
beamlet which reduces the spatial resolution of the dose distribution.
The dose differences are characterised in terms of the 5% and 95% percentile for a sub-
sample of all settings in table 2. Although the maximum dose deviation in a single organ was 
found to be 25 cGy (in bladder) and 39 cGy in the entire body, this represents an outlier and is 
not a good proxy for the similarity of the two dose distributions. The standard deviation error 
was also deemed insufficient in describing the dose difference as it did not follow a normal 
distribution. For all cases investigated, the dose difference appears quite small, only of the 
order of a few cGy.
When analysing the DVH curves for the different VOIs, the beamlet resolution caused no 
discernible difference. This was to be expected from the dose difference distributions and the 
small magnitude of dose difference.
Figure 5. Dose calculated from 5 5×  mm2 beamlets minus dose calculated from 
5 1.25×  mm2 beamlets for patient 2 and CTV+1 mm for a tracked delivery with 
continuous drift motion (left) and for a static delivery (right). The colour scale is set 
between  +25 cGy (green) and  −25 cGy (red).
Table 2. Dose difference due to beamlet resolution in terms of 5% and 95% percentile 
for patient 2 and the CTV+1 mm plan.
Static Tracked (cont. drift)
Percentile 5% [cGy] 95% [cGy] 5% [cGy] 95% [cGy]
Dose difference: 5 5×  mm2 Dij –5 1.25×  mm2 Dij
CTV −3.4 1.3 −4.5 1.2
Rectum −4.9 5.2 −7.5 6.6
Bladder −6.0 5.0 −6.5 6.0
Dose difference: 5 2.5×  mm2 Dij –5 1.25×  mm2 Dij
CTV −1.7 0.4 −1.7 0.1
Rectum −2.1 1.9 −3.0 2.6
Bladder −2.1 1.8 −2.4 2.1
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3.4. Comparison with rigid shift method
When comparing the MLC+VOI translation method used throughout this study with the simpler 
MLC-only translation method (see section 2.3) for a small number of sample cases (figure 6), 
it becomes obvious that both methods produce very similar dose distributions across the CTV. 
For the OARs, however, the difference is pronounced and the MLC-only translation method 
either over or underestimates the OAR dose depending on the most prominent direction of 
motion. For example, for the continuous drift trajectory which steadily drifts posteriorly, the 
rectum D10 dose increases by 50 cGy when comparing the MLC-only with the MLC+VOI 
reconstruction.
3.5. Dosimetric impact of interfractional motion
Figure 7 demonstrates the effect of residual beam-target misalignment caused by inter-
fractional motion for the conventional delivery. When comparing CTV D98 as a function 
of interfractional offset with the zero-offset reference case, i.e. the idealised conventional 
Figure 6. Impact of reconstruction technique on dose for two sample cases. MLC+VOI 
denotes the technique established in this study. MLC-only is an alternative approach 
leaving the target VOI static.
Figure 7. Effect of interfractional and intrafractional motion on CTV D98 for a 
conventional delivery (patient 3, CTV+1 mm, continuous drift) in the sagittal plane 
((a)–(b)) and in 3D (c).
M F Fast et alPhys. Med. Biol. 61 (2016) 1546
1557
delivery with x  =  y  =  z  =  0, it becomes obvious that intrafractional motion can compen-
sate for interfractional offsets (figure 7(a)). The top right quadrant, indicating superior and 
anterior interfractional offsets, is largely free of dose deviations as the prostate drifts back to 
the centre during the delivery for the continuous drift trajectory. Additionally, CTV D98 for 
the offset-shifted conventional deliveries subtracted from the respective offset-shifted static 
delivery is shown in figure 7(b). This allows to isolate the effect of intrafractional motion. 
Interestingly, a large swath of interfractional position offsets is relatively robust against 
intrafractional shifts. This confirms the relatively small effect of continuous drift motion on 
the CTV during the conventional delivery as seen in figure 4. Figure 7(c) confirms for all 
possible combinations of 3D shifts that a combined anterior and superior interfractional shift 
yields the highest CTV D98 dose, whereas a combined posterior and inferior shift yields the 
lowest doses on average.
3.6. Impact of prostate rotations
Figures 8(a) and (b) highlights the impact of prostate rotations about the LR axis (pitch) on the 
CTV D98 dose for tracked deliveries. It is important to keep in mind that during the tracked 
delivery, only the prostate translations are explicitly compensated for, whereas rotations are 
not taken into account. Overall, the effect of the rotation appears to outweigh the effect of 
the intrafractional motion, especially for larger angles of rotation. Plans using the smaller 
1 mm margin appear less robust against rotations than plans with 3 mm margin. For patient 
1, negative pitch rotations result in a dramatic reduction of CTV D98 compared to the static 
reference. At rotation angles smaller than 10− °, CTV D98 even drops below the PTV D95 
prescription of 725 cGy, indicating areas of cold spots for the CTV+1 mm plan. For the same 
patient, the additional effect of simultaneous rotations about the SI axis (roll) appears consid-
erably smaller than the effect of pitch-only rotations. For patients 2 (figure 8(c)) and 3, roll and 
pitch rotations have a similarly detrimental effect on CTV coverage.
4. Discussion
We successfully implemented real-time dose reconstruction for experimental treatment deliv-
eries on a research linac. In terms of the algorithmic performance, our dose reconstruction 
achieves an average memory throughput of 75.6 GB sec−1, which compares very favourably 
Figure 8. Tracked CTV D98 minus respective (unrotated) static CTV D98: ((a)–(b)) as 
a function of the pitch rotation applied to the prostate for all three patients, and (c) as 
a function of pitch and roll rotations for patient 2 (CTV+1 mm, high frequency). Solid 
(dashed) curves correspond to the CTV+1 mm (CTV+3 mm) plan.
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with the 74.5 GB sec−1 measured using the STREAM benchmark1 commonly used for band-
width-limited applications. This indicates that run-times reported here are scalable and that 
further speed-ups are to be expected with improved hardware. Most computations were per-
formed using a default beamlet resolution of 5 5×  mm2. Theoretically a finer sampling of the 
beamlets in the direction parallel to the MLC leaves is beneficial, although the finite voxel 
resolution of the dose grid will counteract some of that benefit. To that effect, we have also 
tested 5 1.25×  mm2 and 5 2.5×  mm2 beamlet resolutions in offline reconstruction mode for 
a static and a tracked delivery. For both deliveries and both beamlet resolutions, the DVHs 
of CTV and OARs remain unaffected by some small local dose deviations of a few cGy. 
A finer sampling in the direction orthogonal to the MLC leaves could increase the accuracy 
for beamlets partially covered by the Y collimators, but was not tested as it is not expected to 
be beneficial for the majority of MLC leaves as beamlets and leaves both have a 5 mm width 
(at the isocenter) and are perfectly aligned.
4.1. Dosimetric results
For three patients and combinations of four plans and four realistic target motion trajecto-
ries, our reconstructed dose distributions highlight the fact that target dose in a single frac-
tion measured in either CTV or PTV can be safely recovered using dynamic MLC tracking. 
This is especially relevant for occasional ‘outlier’ motion events such as the ones seen in 
the high frequency trajectory. It is important to note that dose recovery in the target, i.e. the 
removal of cold spots, is also observed for the smallest investigated margin of 1 mm. We 
selected this lower margin limit to account for residual tracking errors caused by system 
latencies and target detection uncertainties (Fast et al 2014). Whether such small margins 
are really feasible depends, amongst other things, on the level of confidence in the accuracy 
of modern delivery systems. The limited conformity of photon radiotherapy planning due 
to the shallow dose fall-off might in this case be desirable, as it takes care of small motion 
events and some of the microscopic spread. Although high conformity is an objective dur-
ing plan optimisation, the V95% isodose line still extends well beyond the PTV in many 
regions. In terms of the OAR D2 dose, MLC tracking induces both reductions and increases 
depending on the motion model. This could become a concern if clinical dose constrains 
are violated, something which potentially requires a plan adaptation. This study also shows 
that in the case of large prostate rotations, the use of reduced margins without rotating the 
collimator and/or adapting the beam aperture, is potentially unsafe and needs further invest-
igation. Deutschmann et al (2012) have reported mean interfractional rotations about LR of 
5.3 4.9± ° with a maximum rotation of 30.7°, and mean intrafractional rotations of 2.5 2.3± ° 
(maximum: 26.9°), highlighting the significance of these rotations. Their study followed in 
the footsteps of earlier work at the NKI-AvL (Hoogeman et al 2005, Rijkhorst et al 2007), 
which strongly suggested that rotations can be dosimetrically significant, sometimes more so 
than translations, and need to be adapted to.
Special emphasis was put on interfractional motion for the conventional delivery. It was 
shown that for the tight 1 mm CTV-to-PTV margin, the residual beam-to-target misalignment 
can have an impact on the dose distribution and assuming perfect target setups (as was done 
for most of this study) might make the conventional delivery look slightly better than it really 
is. For the tracked delivery it is assumed that small interfractional offsets can be perfectly 
compensated for by MLC tracking as the motion monitoring device does not differentiate 
between intrafractional and interfractional motion.
1 http://www.cs.virginia.edu/stream/ (version 5.10) compiled using gcc 4.8.
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Our results agree well with results for the first clinical prostate tracking trial presented by 
Colvill et al (2015). Using the retrospective dose reconstruction method developed by Poulsen 
et al (2012), the authors show for 15 patients and 475 suitable treatment fractions that MLC 
tracking improves the consistency between planned and delivered dose and recovers dose dur-
ing ‘outlier’ fractions with significant motion events well. In contrast to our study, the authors 
used a dual-arc volumetric delivery and a mix of conventional fractionation and hypofrac-
tionation. For our study, we developed a second dose reconstruction similar to the rigid shift 
method developed by Poulsen et al (2012) (see section 2.3), the main difference being that we 
did not group motion into discrete intervals. We noticed almost identical results for the target 
and different results for the OARs which can be explained by the different assumptions about 
OAR motion (rigidly shifted with target versus static).
Other offline reconstruction approaches for MLC tracking focus on gamma pass/failure 
rate as a quality indicator (Ravkilde et al 2013, 2014). Ravkilde et al (2014) have presented a 
framework in which dose is calculated using a custom-made ‘motion-including’ pencil beam 
convolution algorithm and they verified it against a temporally and spatially resolved dose 
measurement from a biplanar dosimeter. Good agreement was shown when comparing the 
computed dose with the measured dose. Despite several simplifying assumptions in the dose 
calculation, the mean dose calculation time was reported as 259 ms with a temporal resolu-
tion of 500 ms. This is significantly slower and less frequent compared to our study. It is often 
implied that the static dose delivery constitutes the gold standard delivery which needs to be 
matched or improved upon in any adaptive delivery. While this is intuitively correct, there are 
many situations in which this assumption cannot be fulfilled, e.g. when the prostate-to-OAR 
distance decreases, resulting in a change of anatomy. In this study we chose to compare VOI-
specific dose characteristics with the static dose delivery instead of using global measures like 
the gamma pass/fail rate. This is to reflect the reality of treatment planning which is based on 
a set of VOI-specific dose constraints and objectives.
MLC tracking, by design, is only intended to remove the motion-related portion of the mar-
gin. This includes not only intrafractional motion which contributes relatively little to the overall 
margin according to van Herk’s margin recipe (van Herk 2004) based on population statistics, 
but also the proportion of the margin needed for interfractional motion, or to be more accurate, 
residual interfractional motion after employing modern image guidance and couch shifts. It 
cannot reduce other margins such as those related to delineation uncertainty. Generally, small 
prostate margins are met with scepticism since (Engels et al 2009) highlighted the dangers of 
shrinking margins. It should be noted, however, that their study did not use MLC tracking to 
conform the target dose. Another point of criticism might be the microscopic tumour spread of 
tumour tissue into adjacent normal tissue. Sohayda et al (2000) observed extracapsular exten-
sion (ECE), seen even in the earliest stages of localised prostate cancer, in 35% of all investi-
gated prostatectomy specimens. While the mean ECE was 1.1 mm, a maximum extension of 
1 cm was also observed with the majority of cases orientated in the posterolateral direction.
4.2. Limitations and outlook
In this study we relied on certain DVH points such as CTV D98 to characterise entire dose 
distributions. This simplification was necessary in order to reduce the vast amount of data con-
tained in the DVHs, but the exact choice of a DVH point is somewhat arbitrary. Throughout this 
study we limited ourselves to the analysis of single fractions, to exclude any averaging effects 
over multiple fractions with potentially different intrafractional motion in each fraction.
Further limitations of this study are the use of the singular value decomposed pencil beam 
algorithm and more broadly speaking the use of pre-calculated dose influence data. While the 
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pencil beam algorithm is acceptable for prostate, other sites such as lung or liver would profit 
from algorithms better at handling tissue inhomogeneities, such as collapsed-cone or Monte 
Carlo. Due to the modular design of our dose reconstruction software, the choice of physical 
dose engine is flexible and one can be exchanged for the other without affecting the calcul-
ation time. This is especially relevant for applications on MR-guided treatment machines 
where Monte Carlo dose calculation under consideration of the magnetic field is essential. The 
reliance on pre-calculated beamlets might be problematic for very small MLC apertures due to 
the output factor effect, although we tried to avoid such segments in this study. MLC leakage 
and the tongue-and-groove effect were also not accounted for in the beamlets, as leakage was 
previously measured to be below 0.2% and the Agility MLC has defocused leaves without a 
physical tongue-and-groove (Bedford et al 2013). Additionally, more complex motion might 
see the original planning CT completely invalidated. In those cases, pre-calculation of dose is 
impossible. New 3D planning images would need to be acquired in treatment position either 
directly or indirectly through motion models. Very fast Monte Carlo simulations such as the 
one presented by Ziegenhein et al (2015) could become just about fast enough for a real-time 
application in the near future. One way to ease the computational burden would be to reduce 
the number of dose calculations according to the observed motion. In this study, we selected 
a reconstruction frequency of 25 Hz to capture each MLC aperture reported by the linac. It is 
conceivable that this number can be vastly reduced in times when the prostate motion is small 
without compromising the dosimetric accuracy.
Future work should also focus on developing more realistic motion models and assessing 
the impact on the actually delivered dose distribution. This is especially important for the 
OARs, which were considered static for the purpose of this study. In future, MR or in some 
circumstances ultrasound images are expected to prove useful for providing real-time posi-
tion updates not only for the target but also for the OARs. In our software, motion models 
for individual OARs could easily be added without significantly increasing computing times. 
Experiments using deformable phantoms or digital phantoms would then provide a useful way 
of validating the motion model and measuring the actually delivered dose.
This study clearly showns that MLC tracking can change the dose received by normal 
tissues compared to the original treatment plan. This inadvertent change of the fractionation 
might have unintended consequences in terms of the biological effects of normal tissue repair 
and warrants further investigation. Based on the software infrastructure laid out in this study, it 
should also be possible to investigate novel treatment schemes such as the ‘isotoxic’ approach 
in which the target dose is boosted until the OAR dose of a small margin plan is equivalent to 
the OAR dose of a large margin plan.
5. Conclusion
In this study, we have demonstrated that real-time and online dose reconstruction is feasible when 
harnessing modern workstation computers without compromising on spatial resolution or tem-
poral accuracy. We believe that online dose reconstruction will become an important tool for 
creating confidence in tracked treatments. This is also an important milestone towards the imple-
mentation of online re-planning for adaptive radiation therapy and dose-guided tracked MLC 
deliveries. Limitations of our study are the use of pre-calculated dose influence data and the sim-
plistic anatomical model. Keeping these limitations and the small number of patients in mind, ini-
tial evidence has been given that MLC tracking of prostate translations with smaller margins than 
currently recommended could allow for sufficient CTV coverage. Changes of OAR dose occur 
during MLC tracking and are non-negligible. Our results also indicate that prostate rotations can 
have a significant dosimetric effect on the target and should be considered in future work.
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